Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/291073
Title: Phosphatidyl Inositol 3 kinases inhibitor development using novel invitro pharmacological assays
Researcher: Mahesh Yanamandra
Guide(s): Sayan Mitra, Archana Giri
Keywords: Biotechnology and Applied Microbiology
Life Sciences
Microbiology
University: Jawaharlal Nehru Technological University, Hyderabad
Completed Date: 2015
Abstract: The phosphatidyl inositol 3-kinases(PI3Ks) are lipid kinases that regulate the newlinecellular signal transduction pathways involved in cell growth, proliferation, newlinesurvival, apoptosis and adhesion. Deregulations of these pathways are common newlinein oncogenesis and are known to be altered in other metabolic disorders as well. In spite of its huge potential as an attractive target in the above diseases, newlinethere is an unmet need for the development of a successful inhibitor. Unlike protein kinase inhibitor, screening for lipid kinase inhibitor has been challenging due to the lipidic nature of PI3K substrates known as phosphoinositides. Here we report for the first time, the development of unique and novel radioactive lipid kinase screening platform using phosphocellulose newlinepaper that involves transfer of adiolabelled [?P32] ATP to phosphatidylinositol 4,5 phosphate forming Phosphatidylinositol-3,4,5 phosphate captured on the phosphocellulose matrix. Enzyme kinetics and inhibitory properties were established in the plate format using standard inhibitors like LY294002, TGX newline221 and Wortmannin having different potencies towards PI3K isoforms. All the newlineenzyme parameters including ATP and Lipid apparent Km for both were determined and IC50 values generated that matched with historical data. We utilized PI3K ??as an enzyme target to demonstrate phosphocellulose based screening as an excellent platform for the identification of novel chemical entities (NCEs) in PI3K drug discovery and later extended in all isoforms ( PI3K ?, PI3K ?, and PI3K ?). This unique assay methodology was further extended to study inhibitor characterization and evaluated the mechanism of action (MOA) of PI3K inhibitors (LY294002 and TGX-221) with respect to ATP competitiveness against PI3 kinase ?? This robust method can be easily newlineadapted in any lipid kinase drug discovery program for compound profiling and in-depth mechanistic applications without having any potential artifacts. newline
Pagination: 197p.
URI: http://hdl.handle.net/10603/291073
Appears in Departments:Faculty of Biotechnology

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File137.91 kBAdobe PDFView/Open
02_declaration.pdf203.31 kBAdobe PDFView/Open
03_certificate.pdf434.44 kBAdobe PDFView/Open
04_acknowledgement.pdf69.39 kBAdobe PDFView/Open
05_abstract.pdf139.78 kBAdobe PDFView/Open
06_contents.pdf167.06 kBAdobe PDFView/Open
07_list of figures_tables.pdf177.8 kBAdobe PDFView/Open
08_chapter 1.pdf1.19 MBAdobe PDFView/Open
09_chapter 2.pdf488.59 kBAdobe PDFView/Open
10_chapter 3.pdf270.52 kBAdobe PDFView/Open
11_chapter 4.pdf741.11 kBAdobe PDFView/Open
12_chapter 5.pdf201.51 kBAdobe PDFView/Open
13_annexure.pdf218.66 kBAdobe PDFView/Open
14_references.pdf173.57 kBAdobe PDFView/Open
80_recommendation.pdf333.64 kBAdobe PDFView/Open
Show full item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: